Introducing Hyaluronic Acid, Exosomes, and PDRN

SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler designed to redefine skin hydration and revitalization.

Maypharm Co., Ltd. is set to revolutionize the aesthetic industry with the introduction of Hyalmass Aqua-Exosome. This cutting-edge hybrid filler combines the power of hyaluronic acid, exosomes, and PDRN to maximize skin hydration, elasticity, and regeneration.

Hyalmass Aqua-Exosome is a breakthrough in aesthetic innovation, offering unmatched benefits for skin health and rejuvenation. Unlike traditional hydration fillers that focus solely on moisture, Hyalmass Aqua-Exosome elevates skin health standards by leveraging the regenerative potential of exosomes and PDRN.

"At Maypharm, we are committed to pushing the boundaries of aesthetic technology to deliver transformative results for our customers," says KWON JONGWOOK, CEO of Maypharm Co., Ltd. "With Hyalmass Aqua-Exosome, we aim to provide a comprehensive solution that not only hydrates the skin but also promotes long-term elasticity and regeneration."

Key Features of Hyalmass Aqua-Exosome:

Advanced Formulation: Hyalmass Aqua-Exosome contains a unique blend of hyaluronic acid, exosomes derived from human stem cell conditioned media and plant sources, and PDRN (polydeoxyribonucleotide). This innovative combination maximizes skin regeneration and elasticity, resulting in visibly smoother and more radiant skin.
Prefilled Syringes: Hyalmass Aqua-Exosome comes conveniently packaged in prefilled syringes, ensuring optimal hygiene and safety for both patients and practitioners.
Long-lasting Efficacy: Utilizing high-purity, high-molecular-weight raw materials, Hyalmass Aqua-Exosome delivers long-lasting benefits to the skin, enhancing its viscoelasticity and overall vitality.
Stimulates Fibroblasts: The primary ingredient in Hyalmass Aqua-Exosome stimulates fibroblasts to promote collagen and elastin production, leading to improved skin elasticity, anti-aging effects, and enhanced skin regeneration.

In comparison to traditional hydration fillers, Hyalmass Aqua-Exosome emerges as the superior choice. While conventional hydration fillers deliver quick moisture, their benefits are often limited to hydration alone, offering minimal regenerative effects. In contrast, Hyalmass Aqua-Exosome not only provides immediate hydration with hyaluronic acid but also promotes long-term skin elasticity and regeneration through the inclusion of exosomes and PDRN. This innovative formulation leads to a significant overall improvement in skin condition, positioning Hyalmass Aqua-Exosome as a revolutionary advancement in aesthetics.

With the launch of Hyalmass Aqua-Exosome, Maypharm Co., Ltd. continues its commitment to innovation, excellence, and customer satisfaction in the field of cosmetic medicine and dermo-cosmetic products. Experience the future of medical and aesthetics with Hyalmass Aqua-Exosome and unlock the secret to radiant, youthful-looking skin.

Partnership with Beauty Factory:

The production of Hyalmass Aqua-Exosome is supported by Beauty Factory, a leading Korean medical aesthetics manufacturer renowned for its commitment to innovation and quality. While Maypharm is responsible for the global distribution and commercialization of Hyalmass Aqua-Exosome, Beauty Factory's advanced manufacturing capabilities ensure that this product meets the highest industry standards.

Beauty Factory operates state-of-the-art facilities that comply with international Good Manufacturing Practice (GMP) guidelines. With their proprietary HALO manufacturing technology, developed through partnerships with prestigious academic institutions like KINS Lab at Seoul National University and the Biomaterial Synthesis Lab at Sookmyung University, Beauty Factory maintains its leadership in medical aesthetics. Their collaborations with renowned global R&D partners in Poland and Germany further enhance the scientific and technological advancements that support the creation of Hyalmass Aqua-Exosome.

Quality Control at Beauty Factory:

Beauty Factory's rigorous quality control process ensures that every product, including Hyalmass Aqua-Exosome, meets the highest standards for safety and efficacy. With a 7-step quality control (QC) system in place, Beauty Factory guarantees that all products undergo meticulous testing to ensure consistent and reliable performance across all applications.

Maypharm, in collaboration with Beauty Factory, is excited to introduce a product that combines cutting-edge technology and advanced formulation to not only provide immediate skin hydration but also support long-term skin health and rejuvenation, establishing a new standard in the aesthetic industry.

For more information about Hyalmass Aqua-Exosome and other products from Maypharm Co., Ltd., please visit www.maypharm.net or contact sales@maypharm.co.kr.

Photo -
Photo -
Photo -

View original content:https://www.prnewswire.co.uk/news-releases/maypharm-unveils-revolutionary-hybrid-filler-hyalmass-aqua-exosome-the-future-of-skin-hydration-and-regeneration-302339519.html

Images

Tags

More Like This

MAYPHARM CO., LTD. Launches SKINCOLLA: The World's First Recombinant Human Collagen Filler for Superior Skin Rejuvenation

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

Kimera® Labs Named Semifinalist in $101 Million XPRIZE Healthspan Competition for Pioneering Innovations in Healthy Aging

Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing

Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio

Kimera® Labs Inc publishes novel brain targeting of exosomes in Nature Scientific Reports

From the surface to the deep structure of the face: IBSA Derma presents the new frontier of adipose tissue restoration in response to aging